These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 34019865)
61. Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer. Kim B; Park SJ; Cheon JH; Kim TI; Kim WH; Hong SP World J Gastroenterol; 2014 Apr; 20(15):4370-6. PubMed ID: 24764675 [TBL] [Abstract][Full Text] [Related]
62. NTRK Gene Fusion Detection in Atypical Spitz Tumors. Cappellesso R; Nozzoli F; Zito Marino F; Simi S; Castiglione F; De Giorgi V; Cota C; Senetta R; Scognamiglio G; Anniciello AM; Cesinaro AM; Mandalà M; Gianatti A; Valente MG; Valeri B; Sementa AR; Ricci C; Corti B; Roviello G; Dei Tos AP; Franco R; Massi D Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830218 [TBL] [Abstract][Full Text] [Related]
63. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767 [TBL] [Abstract][Full Text] [Related]
64. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis. Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935 [TBL] [Abstract][Full Text] [Related]
65. Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer. Maestro ML; Vidaurreta M; Sanz-Casla MT; Rafael S; Veganzones S; Martínez A; Aguilera C; Herranz MD; Cerdán J; Arroyo M Ann Surg Oncol; 2007 Mar; 14(3):1229-36. PubMed ID: 17195912 [TBL] [Abstract][Full Text] [Related]
66. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer. Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427 [TBL] [Abstract][Full Text] [Related]
67. Mutational profiling of colorectal cancers with microsatellite instability. Lin EI; Tseng LH; Gocke CD; Reil S; Le DT; Azad NS; Eshleman JR Oncotarget; 2015 Dec; 6(39):42334-44. PubMed ID: 26517354 [TBL] [Abstract][Full Text] [Related]
68. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms. Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007 [TBL] [Abstract][Full Text] [Related]
69. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas. Mescam-Mancini L; Lantuéjoul S; Moro-Sibilot D; Rouquette I; Souquet PJ; Audigier-Valette C; Sabourin JC; Decroisette C; Sakhri L; Brambilla E; McLeer-Florin A Lung Cancer; 2014 Feb; 83(2):168-73. PubMed ID: 24380695 [TBL] [Abstract][Full Text] [Related]
70. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. Heald B; Plesec T; Liu X; Pai R; Patil D; Moline J; Sharp RR; Burke CA; Kalady MF; Church J; Eng C J Clin Oncol; 2013 Apr; 31(10):1336-40. PubMed ID: 23401454 [TBL] [Abstract][Full Text] [Related]
71. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125 [TBL] [Abstract][Full Text] [Related]
72. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas. Zhang Z; Pang J; Chen L; Chen J; Li J; Liu H; Wang J; Wu H; Liang Z Hum Pathol; 2022 Nov; 129():21-31. PubMed ID: 35977594 [TBL] [Abstract][Full Text] [Related]
73. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features. Pan Y; Zhang Y; Li Y; Hu H; Wang L; Li H; Wang R; Ye T; Luo X; Zhang Y; Li B; Cai D; Shen L; Sun Y; Chen H Lung Cancer; 2014 May; 84(2):121-6. PubMed ID: 24629636 [TBL] [Abstract][Full Text] [Related]
74. MSH3 protein expression and nodal status in MLH1-deficient colorectal cancers. Laghi L; Bianchi P; Delconte G; Celesti G; Di Caro G; Pedroni M; Chiaravalli AM; Jung B; Capella C; de Leon MP; Malesci A Clin Cancer Res; 2012 Jun; 18(11):3142-53. PubMed ID: 22496206 [TBL] [Abstract][Full Text] [Related]
75. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955 [TBL] [Abstract][Full Text] [Related]
76. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma. Su YJ; Lee YH; Jin YT; Hsieh MS Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876 [TBL] [Abstract][Full Text] [Related]